MTG Co., Ltd.
7806・Growth Market・Other Products
Business
MTG Co., Ltd. was founded in 1996 and is headquartered in Nagoya, Aichi Prefecture, as a beauty and health device manufacturer with "VITAL LIFE" as its business vision. Its flagship brands are ReFa (Hair Care & Beauty Devices), launched in 2009, and SIXPAD (EMS Training Devices), launched in 2015. Sales channels are categorized into six segments—Direct Marketing, Professional Business, Retail Store Business, Global Business, Smart Ring Business, and Other Businesses—delivering products to consumers and corporate clients both in Japan and overseas through diverse touchpoints ranging from e-commerce to hair salons, hotels, and department stores. Consolidated net sales for FY2025 (ended September 2025) reached ¥98,810 million, and the company is listed on the Tokyo Stock Exchange Growth Market.
Business Model
The company develops products through a proprietary brand development system that integrates four elements—Creation, Technology, Branding, and Marketing—and sells them mainly through three channels: Direct Marketing (EC and mail order), Professional (B2B2C such as hair salons and hotels), and Retail Store (department stores and mass merchandisers). The structure aims to improve LTV through repeat demand cultivated via the B happy platform and ReFa Room installations, as well as stock-type businesses such as Smart Plan. The company invested ¥3,423 million (FY2025, ending September 2025) in R&D expenses, maintaining product competitiveness through industry-government-academia collaboration.
Company Strengths
ReFa hair care products swept the top 3 positions in WWD JAPAN's Best Cosmetics 2025 (First Half) and secured the No.1 ranking by number of entries among all brands. The Lock series, including ReFa LOCK OIL, achieved the No.1 domestic brand share in the hair styling agent category. The products have also achieved the No.1 daily ranking in Rakuten's hair care ranking, providing data-backed evidence of product strength.
The B happy platform has 36,657 member stores, with 44,360 contracted hair salons (exceeding the initial fiscal year target of over 42,000 salons), and ReFa Room installations have reached a cumulative total of 3,840 facilities and 84,700 rooms, with an estimated monthly experience count of over 1.74 million people. A cyclical model has been established in which lodging and salon experiences spill over into purchases, and maintaining a high repeat rate contributes to stable earnings.
In FY2025 (ending September 2025), the company achieved consolidated net sales of ¥98,810 million (up 37.5% year on year) and operating profit of ¥10,665 million (up 225.4% year on year). The three main channels all achieved strong growth together, with the Retail Store Business up 55.7% year on year, the Direct Marketing Business up 29.5%, and the Professional Business up 29.0%. This was supported by the opening of 27 new stores during the year and the introduction of displays at approximately 1,800 consumer electronics retail stores.
ENVALITH's Perspective
Performance Trend
Revenue over the past five fiscal years expanded 2.3x, from ¥42,799 million (FY2021) to ¥98,810 million (FY2025). In H1 FY2026 (ending September 2026) (October 2025 to March 2026), the company achieved high growth across all metrics: revenue of ¥66,523 million (up 42.5% YoY), operating income of ¥10,022 million (up 36.0% YoY), ordinary income of ¥9,963 million (up 33.4% YoY), and net income attributable to owners of the parent for the interim period of ¥7,825 million (up 68.1% YoY). The Retail Store Business was the largest driver, up 83.7% YoY, while the Direct Marketing Business also performed solidly, up 34.9%. In terms of the external environment, an increase in personal consumption backed by economic policy and wage growth served as a tailwind, while a global surge in resource prices and rapid currency fluctuations have introduced cost-side uncertainty. The full-year forecast has already been revised upward to revenue of ¥135,000 million (up 36.6% year on year) and operating income of ¥15,000 million (up 40.6% year on year).
Growth Strategy
Aiming for sustainable growth through three pillars: focused investment in ReFa and SIXPAD, deepening of stock-type businesses, and creation of synergies with Kirala
Continuing to introduce new products across a wide range of categories including hair care, skin care, fragrance, inner care, and VITAL TECH. ReFa HONEY QUEEN HAIR CARE SERIES, ReFa MILK PROTEIN STRAIGHT LINE, ReFa THE PERFUME HAIR MIST and other products were successively launched during the interim period, advancing the acquisition of new customer segments and strengthening the revenue base.
During the interim period, 5 new department store locations, 3 shopping center locations, and 3 outlet locations were opened. ReFa GINZA (opened November 2025) surpassed 160,000 visitors within four months. It functions as a hub for outreach to 124 countries worldwide, and the company is concurrently pursuing enhanced brand recognition and sales uplift through renovations of existing stores (3 locations).
Rolling out a usage-based smart plan for ReFa HYDRAID in the beauty salon market to deepen the recurring revenue model. Expanding the installation of ReFa Room in lodging facilities (cumulative total of 4,137 facilities and 110,356 rooms) and the adoption of ReFa hair care cosmetics by hotels (cumulative total of 348 facilities), strengthening the experience-driven purchase cycle and repeat revenue.
In October 2025, Kirala was made a wholly owned subsidiary at an acquisition cost of ¥3,912 million. The company aims to create cross-selling synergies among the Total Life Service Platform (Kirala) business, the high-end market expansion of the natural water brand "Toki," and the beauty device brand "STELLA BEAUTE." Goodwill of ¥1,443 million (amortized on a straight-line basis over 20 years) has arisen, and realizing these synergies is key to earnings contribution.
In the femtech category launched in September 2025, "SIXPAD Perine Fit" was released in January 2026, achieving sales performance exceeding the initial plan. In the medical field, the company is advancing evidence-building through participation in the Japanese Society for Surgery of the Foot's annual academic meeting and other activities, aiming to deepen product understanding among medical professionals and promote potential clinical applications.
Last updated: July 17, 2026

